Ultragenyx Pharmaceutical Inc.

Erste Asset Management GmbH RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

15,010

Value ($000)

296

Weight

0.0%

2018 Q4 - 2025 Q4 (29 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	296	0.0%	15,010	12/31/2025
2025 Q3	11/12/2025	456	0.0%	15,010	9/30/2025
2025 Q2	8/14/2025	636	0.0%	17,421	6/30/2025
2025 Q1	5/14/2025	568	0.0%	15,010	3/31/2025
2024 Q4	2/10/2025	652	0.0%	15,010	12/31/2024
2024 Q3	11/14/2024	817	0.0%	15,010	9/30/2024
2024 Q2	11/26/2024	622	0.0%	15,010	6/30/2024
2024 Q1	11/26/2024	703	0.0%	15,010	3/31/2024
2023 Q4	11/26/2024	725	0.0%	15,010	12/31/2023
2023 Q3	11/26/2024	528	0.0%	15,010	9/30/2023
2023 Q2	11/26/2024	700	0.0%	15,010	6/30/2023
2023 Q1	11/26/2024	580	0.0%	15,010	3/31/2023
2022 Q4	11/26/2024	678	0.0%	15,010	12/31/2022
2022 Q3	11/26/2024	609	0.0%	15,010	9/30/2022
2022 Q2	11/26/2024	904	0.0%	15,010	6/30/2022
2022 Q1	11/25/2024	1,071	0.0%	15,010	3/31/2022
2021 Q4	11/25/2024	1,424	0.0%	17,210	12/31/2021
2021 Q3	11/25/2024	1,482	0.0%	17,210	9/30/2021
2021 Q2	11/25/2024	1,657	0.0%	17,210	6/30/2021
2021 Q1	11/25/2024	1,929	0.0%	17,210	3/31/2021
2020 Q4	11/25/2024	2,537	0.1%	17,210	12/31/2020
2020 Q3	11/25/2024	1,567	0.1%	18,410	9/30/2020
2020 Q2	11/22/2024	7,249	0.3%	95,310	6/30/2020
2020 Q1	11/22/2024	4,230	0.2%	95,310	3/31/2020
2019 Q4	11/22/2024	4,101	0.2%	95,310	12/31/2019
2019 Q3	11/22/2024	4,065	0.2%	95,310	9/30/2019
2019 Q2	11/22/2024	5,987	0.3%	95,310	6/30/2019
2019 Q1	11/22/2024	6,564	0.4%	95,310	3/31/2019
2018 Q4	11/26/2024	3,678	0.2%	87,710	12/31/2018